Work

BH3 mimetic and dual PI3K/mTOR inhibitor attenuates gemcitabine resistance in triple-negative breast cancer

Year: 2025

Type: article

Source: Medical Oncology

DOI: 10.1007/s12032-025-03143-z

Authors: Gizem Selimoglu, Suranur Ayvaz, Zeynep Busra Bolat

Institutions: Sağlık Bilimleri Üniversitesi, Karadeniz Technical University

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416387599

FWCI: 0.597

Cites: 51

Cited by: 2

Related to: 10